Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluocinolone Acetonide for Radiation Retinopathy
NCT03238157Phase 3Withdrawn
- Sponsor
- Cleveland Clinic
- Start
- Feb 2022
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluocinolone in radiation retinopathy (RR), sponsored by Cleveland Clinic. Planned start Feb 2022; status: withdrawn.
02
Drugs
fluocinolone
03
Conditions
radiation retinopathy (RR)
Beyond the preview
Go deeper on NCT03238157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03238157.